Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
Patrick Harrington, Hugues de Lavallade, Katie J. Doores, Amy O’Reilly, Jeffrey Seow, Carl Graham, Thomas Lechmere, Deepti Radia, Richard Dillon, Yogita Shanmugharaj, Andreas Espehana, Claire Woodley, Jamie Saunders, Natalia Curto-Garcia, Jennifer O’Sullivan, Kavita Raj, Shahram Kordasti, Michael H. Malim, Claire Harrison, Donal McLornan
doi: https://doi.org/10.1101/2021.04.27.21256096
Patrick Harrington
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
2School of Cancer and Pharmaceutical Science, King’s College London. London, U.K.
Hugues de Lavallade
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
2School of Cancer and Pharmaceutical Science, King’s College London. London, U.K.
3Department of Haematological Medicine, King’s College London School of Medicine, London, UK
Katie J. Doores
4Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Amy O’Reilly
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Jeffrey Seow
4Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Carl Graham
4Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Thomas Lechmere
4Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Deepti Radia
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Richard Dillon
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
5Department of Medicine and Molecular Genetics, King’s College London, London. U.K.
Yogita Shanmugharaj
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Andreas Espehana
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Claire Woodley
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Jamie Saunders
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Natalia Curto-Garcia
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Jennifer O’Sullivan
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Kavita Raj
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
Shahram Kordasti
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
2School of Cancer and Pharmaceutical Science, King’s College London. London, U.K.
Michael H. Malim
4Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
Claire Harrison
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
2School of Cancer and Pharmaceutical Science, King’s College London. London, U.K.
Donal McLornan
1Department of Clinical Haematology, Guy’s & St Thomas’ NHS Foundation Trust, London, U.K.
2School of Cancer and Pharmaceutical Science, King’s College London. London, U.K.
Data Availability
The datasets generated during and analysed during the current study are available from the corresponding author on reasonable request.
Posted May 11, 2021.
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
Patrick Harrington, Hugues de Lavallade, Katie J. Doores, Amy O’Reilly, Jeffrey Seow, Carl Graham, Thomas Lechmere, Deepti Radia, Richard Dillon, Yogita Shanmugharaj, Andreas Espehana, Claire Woodley, Jamie Saunders, Natalia Curto-Garcia, Jennifer O’Sullivan, Kavita Raj, Shahram Kordasti, Michael H. Malim, Claire Harrison, Donal McLornan
medRxiv 2021.04.27.21256096; doi: https://doi.org/10.1101/2021.04.27.21256096
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
Patrick Harrington, Hugues de Lavallade, Katie J. Doores, Amy O’Reilly, Jeffrey Seow, Carl Graham, Thomas Lechmere, Deepti Radia, Richard Dillon, Yogita Shanmugharaj, Andreas Espehana, Claire Woodley, Jamie Saunders, Natalia Curto-Garcia, Jennifer O’Sullivan, Kavita Raj, Shahram Kordasti, Michael H. Malim, Claire Harrison, Donal McLornan
medRxiv 2021.04.27.21256096; doi: https://doi.org/10.1101/2021.04.27.21256096
Subject Area
Subject Areas
- Addiction Medicine (372)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2756)
- Dermatology (235)
- Emergency Medicine (414)
- Epidemiology (12405)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4266)
- Geriatric Medicine (396)
- Health Economics (700)
- Health Informatics (2760)
- Health Policy (1020)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (454)
- Neurology (4046)
- Nursing (216)
- Nutrition (600)
- Oncology (2132)
- Ophthalmology (606)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1149)
- Primary Care Research (470)
- Public and Global Health (6659)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (421)
- Sports Medicine (353)
- Surgery (465)
- Toxicology (57)
- Transplantation (192)
- Urology (171)